TMC Life Sciences Berhad (KLSE:TMCLIFE)

Market Cap	766.43M -2.2%
Revenue (ttm)	387.04M +18.6%
Net Income	15.16M +586.7%
EPS	0.01 +586.7%
Shares Out	1.74B
PE Ratio	50.57
Forward PE	n/a
Dividend	0.00 (0.42%)
Ex-Dividend Date	Dec 8, 2025

Volume	83,800
Open	0.4450
Previous Close	0.4450
Day's Range	0.4350 - 0.4450
52-Week Range	0.3800 - 0.5750
Beta	0.35
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About TMC Life Sciences Berhad

TMC Life Sciences Berhad, an investment holding company, provides healthcare services in Malaysia. The company operates Thomson Hospital Kota Damansara hospital located in prime alcove of Kota Damansara. It is involved in providing multi-disciplinary tertiary care, traditional and complementary, obstetrics and gynaecology, fertility services; operating fertility centres and women clinics; property investment; providing pharmacy services and products; management support services; development, marketing, and management of healthcare programmes; a...

• Industry: Miscellaneous Health And Allied Services, Not Elsewhere Classified
• Founded: 1994
• Country: Malaysia
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: TMCLIFE

Financial Performance

In fiscal year 2025, TMC Life Sciences Berhad's revenue was 345.63 million, a decrease of -0.23% compared to the previous year's 346.42 million. Earnings were 3.61 million, a decrease of -91.13%.